His work is sponsored by the U.S. Geologic Survey and the Long Island Sound Fund of Connecticut's Department of Environmental Protection. -- David N. Leff Science Editor (c) 1997 American Health Consultants
Yoder suggested that once the mechanism is understood, "more gene shuffling could be done" to introduce the resistance factor into other plants. -- David N. Leff Science Editor (c) 1997 American Health Consultants
The role of Pla in plague," the researchers suggest, "implies that this class of proteases may contribute, in a more subtle way, to the capacity of less virulent species to produce disseminated infection, a major source of mortality for immunocompromised patients." -- David N. Leff Science Editor (c) 1997 American Health Consultants
Tanabe, on the other hand, informed the AACR meeting here last May of his finding that "primary colon carcinomas, and liver and lymph-node metastases overexpressed a specific epithelial CD44 isoform, know as CD44R1, whereas paired normal mucosa did not." -- David N. Leff 110592CD44 -- David N. Leff Science Editor (c) 1997 American Health Consultants
These workshops would probably be held "within the next several months," Maryanski said. -- David N. Leff Science Editor (c) 1997 American Health Consultants
Besides its cancer program, Somatix is focusing its gene therapy R&D on Parkinson's disease and hemophilia, Carter said. -- David N. Leff Science Editor (c) 1997 American Health Consultants
Thus, in Friday's issue of Cell, Michael S. Brown and Joseph L. Goldstein, who shared a Nobel prize in 1985 for elucidating cholesterol metabolism in the body, wrote: "By crossbreeding with the apoE mutant mice, at last the full power of mouse genetics will be available to unravel a multifactorial disease." -- David N. Leff Science Editor (c) 1997 American Health Consultants
At 2,500 kilobases, it's too big to stuff into an expression vector, so we're putting our money on minigenes." -- David N. Leff Science Editor (c) 1997 American Health Consultants
HSV-1 vectors may be a promising new gene therapy approach to Parkinson's disease," Geller said, but noted that before his technique can go from rodents to humans, the vector needs a deletion mutant as a helper virus, which does not revert to wild type. -- David N. Leff Science Editor (c) 1997 American Health Consultants
But since Viagene does not receive any NIH funding, the company does not require its permission to proceed. -- David N. Leff Science Editor (c) 1997 American Health Consultants
And we view an industry-government collaboration in this area as absolutely critical to success." -- David N. Leff Science Editor (c) 1997 American Health Consultants
Also participating in the leukotriene sweepstakes are Rhone- Poulenc Rorer, Hoechst-Roussel Pharmaceuticals and Schering- Plough Research Institute. -- David N. Leff Science Editor (c) 1997 American Health Consultants
In the Dallas study, the thrombolytic was administered by paramedics in ambulances, while doctors administered the drug in Scotland to patients at home. -- David N. Leff Science Editor (c) 1997 American Health Consultants
Rosenberg is planning early studies in pigs and primates, followed "within two years" by trials in humans. -- David N. Leff Science Editor (c) 1997 American Health Consultants
His work is sponsored by the U.S. Geologic Survey and the Long Island Sound Fund of Connecticut's Department of Environmental Protection. -- David N. Leff Science Editor (c) 1997 American Health Consultants